A prominent feature of the rodent Muc3 SEA module is the precursor cleavage event that segregates the O-glycosylated N-terminal fragment and transmembrane domain into the noncovalently attached heterodimer. There are seven potential N-glycosylation sites that occur in a cluster in the SEA module of Muc3. However, it is unknown if these sites are modified or what the function of these N-glycans may be in the SEA module. Our data show that the proteolytic cleavage of the rodent Muc3 SEA module was partially prevented by treatment with tunicamycin, an inhibitor of N-glycosylation. Each single mutant of the seven N-glycosylation sites (N1A, N2A, N3A, N4A, N5A, N6A, and N7A) and multiple mutants, including double (N34A) and triple (N345A) mutants, and mutants with four (N3457A), five (N34567A), six (N134567A and N234567A), seven (N1234567A) mutations, confirmed that all seven of these potential sites are N-glycosylated simultaneously. The proteolytic cleavage of the SEA module was not affected when it lacked only one, two, or three N-glycans, but was partially inhibited when lacking four, five, and six N-glycans. In all, 2%, 48%, 85%, and 73% of the products from N3457A, N34567A, N134567A, and N234567A transfectants, respectively, remained uncleaved. The proteolytic cleavage was completely prevented in the N1234567A transfectant, which eliminated all seven N-glycans in the SEA module. The interaction of the heterodimer was independent of the N-glycans within the rodent Muc3 SEA module. Thus, the N-glycosylation pattern constituted a control point for the modulation of the proteolytic cleavage of the SEA module.
Introduction
Transmembrane-tethered mucins and their soluble counterparts are found in epithelial linings throughout the body. Based upon the knowledge of their structure, surface location, and expression patterns, it is believed that these molecules play an important role in barrier function. In addition to having extended, 1 To whom correspondence should be addressed: Tel: +23-65478216 (H), +23-68754124; Fax: +23-65410853; e-mail: rongquanw@hotmail.com 2 These authors contribute equally.
heavily glycosylated domains on the cell surface, structural features within the carboxy-terminal regions suggest that many, if not all, membrane mucins may have the ability to shed their extracellular domain and/or to engage in cell-signaling processes via their cytoplasmic tails (Carraway et al. 1999; McNeer et al. 1998; Baruch et al. 1999) . Human mucins, MUC1 and MUC4, for example, have been implicated in the regulation of cell adhesion, growth, and differentiation (Carraway et al. 2000; Schroeder et al. 2001) . Excessive shedding or release of mucin extracellular domains is also a prominent characteristic of metastatic carcinoma, inflammatory bowel disease, and cystic fibrosis (Smorodinsky et al. 1996; Parmley and Gendler 1998; Shirazi et al. 2000; Buisine et al. 2001; Khatri et al. 2001) .
The SEA domain, or SEA module, was first identified as a module commonly found in sea-urchin sperm protein, enterokinase and agrin (Bork and Patthy 1995) . Most proteins with SEA modules are membrane proteins and usually have only one SEA module. SEA modules consist of about 120 residues (Wreschner et al. 2002) , always exist in the extracellular region and often are accompanied by O-linked polysaccharides at the N-terminal side. Previous studies have speculated about the properties of SEA modules. The deletion of the SEA module of perlecan affects heparan sulfate synthesis (Dolan et al. 1997) . The sitespecific cleavage of SEA modules has been reported for human MUC1, MUC3, MUC12, MUC17, and Ig-hepta (Gum et al 2002; Abe et al. 2002; Palmai-Pallag et al. 2005 ). All of these cleavages occur between glycine and serine in the GSVVV motif, located in the middle of the SEA modules.
We have previously published (Wang et al. 2002; Khatri et al. 2003 Khatri et al. , 2004 Li et al. 2008) evidence that the expressed C-terminal domain or C-terminal domain plus three tandem repeats (TRs) of the rodent membrane mucin, Muc3, undergoes two proteolytic cleavages during an early period of biosynthesis in the endoplasmic reticulum (ER). One cleavage was found to occur between glycine and serine within the LSKGSIVV motif, and the other was unidentified. The N-terminal 30 kDa cleavage fragment remained associated with the 49 kDa C-terminal membrane-tethered fragment via noncovalent, disulfide bondindependent interactions. Recently, the cleavage within the SEA module of human MUC1 was identified as an autocatalytic reaction, and the mechanism for this cleavage was elucidated (Levitin et al. 2005; Macao et al. 2006) . However, the sequence similarity between the 104 amino acids that constitute the human MUC1 SEA module and the 174 residues of the rat Muc3 SEA module is only 6.9% (12/174) (Figure 1 ). Due to the lack of sequence homology between the MUC1 SEA module and the rat Muc3 SEA module, the finding that the clusters of Nglycosylation sites are essential for the cleavage reaction in the MUC1 SEA module cannot be extrapolated to other mucins. The biological purpose of the cleavage and the association of cleavage fragments are not understood, but are possibly important for the later release of the soluble extracellular domain into the intestinal lumen.
Within the SEA module of rat Muc3, there are seven potential N-glycosylation sites with the consensus sequence, N-X-S/T, in which X can be any amino acid except proline. There is a conservation of the distribution of N-glycosylation sites between SEA module of rat Muc3 and SEA modules of human MUC17, MUC3A, MUC3B, MUC12, and rat GPR116, but there is little conservation of the distribution of N-glycosylation sites between SEA module of rat Muc3 and SEA modules of human MUC1, ENTK, Agrin, PGEM, and MUC16 (Figure 1 ). However, understanding which N-glycosylation sites are actually used and how much N-glycosylation affects other posttranslational modifications, protein maturation, and function of the protein remains to be elucidated. In order to identify the role of potential Nglycosylation sites in the posttranslational processing of the rodent Muc3 SEA module, we mutated the N-glycosylation site(s) and observed the possible effects on the proteolytic cleavage of the precursor, and on the association of subunits caused by the lack of the N-glycan(s). Our results leave open the possibility that N-glycans within the SEA module of rMuc3 somehow directly facilitate ER cleavage at the LSKG/SIVV site which we have confirmed that the proteolytic cleavage of rodent Muc3 carboxyl terminus occurs within 15 min of protein synthesis based on the pulse/chase experiment (Wang et al. 2002) .
Results

Tunicamycin partially inhibited proteolytic cleavage of the rodent Muc3 C-terminal domain
The carboxy-terminal domain of rodent Muc3 was cloned in the eukaryotic expression plasmid, pSecTag2, and expressed in COS-1 cells. The expressed Muc3 C-terminal domain was tagged with a V5 epitope at the N-terminus, and Myc and polyhistidine epitopes at the C-terminus (Figure 2 ). The biological purpose for these seven N-glycosylated sites in the SEA module, which serve as a domain for the proteolytic cleavage, association, and possible dissociation of the cleaved fragments in SEA domain-containing proteins, was unclear. Tunicamycin was used to inhibit the synthesis of N-glycans in p20-transfected COS-1 cells, and then used pulse/chase experiments to determine if the proteolytic cleavage was prevented by the treatment of tunicamycin in p20 transfected COS-1 cells.
In pulse/chase experiments, cells used for transfection with wild-type p20 or its counterpart p20s/a, in which the cleavage Y He et al. Fig. 2 . Schematic representation of rMuc3 constructs. cDNA (p20) for the C-terminal 380 amino acids of rMuc3 was cloned into the expression vector pSecTag2, "EGF1", "EGF2", "SEA", and "TM" represent two EGF-like domains, the SEA module and TM region, respectively. "V5", "M", "His", and "C-tail" refer to V5, Myc, polyhistidine tags, and cytoplasmic tail, respectively. "N1", "N2", "N3", "N4", "N5", "N6" and "N7" refer to the seven N-glycosylation sites (N-X-S/T, in which X can be any amino acid except proline). "A" refers to the mutated site (A-X-S/T). "N1A", "N2A", "N3A", "N4A", "N5A", "N6A", and "N7A" refer to single mutations, "N34A" refers to the double mutant, "N345A" refers to the triple mutant, "N3457A" refers to four mutations, "N34567A" refers to five mutations, "N134567A" and "N234567A" refer to six mutations, and "N1234567A" refers to seven mutations of the N-glycosylation sites. The cleavage motif (LSKG/SIVV) was resided between two EGF domains.
site, G/S, was mutated to G/A, were treated with tunicamycin (20 μg/mL) for 2 h. Cell lysates were immunoprecipitated with an anti-V5 antibody and the labeled products were analyzed by SDS-PAGE and autoradiography. In the absence of tunicamycin, the p20 construct expressed the usual laddered 49 and 30 kDa fragments, while cells grown in the presence of tunicamycin produced bands at 60, 41, and 22 kDa ( Figure 3B ), the 60 kDa band was the most predominant product, it is consistent with the expected molecular weights ( Figure 3A) . In p20 transfectants, tunicamycin caused the noncleaved, nonglycosylated 60 kDa product to accumulate. The relevant 60 kDa band was also seen in the case of p20s/a transfectants, which were previously confirmed to produce the uncleaved, full-length product, and the proteolytic cleavage at the G/S site of the LSKGSIVV motif was totally prevented. Thus, tunicamycin caused a partial inhibition of rMuc3 domain cleavage. Because tunicamycin exerts broad effects, preventing the N-linked glycosylation of all or most glycoproteins in cells, the partial inhibition of cleavage in p20 transfectant cannot necessarily be ascribed to the lack of N-glycans within the SEA module of the rMuc3 carboxyl terminus.
This result raised two possibilities. One is that the seven N-glycans residing in the SEA module of the rodent Muc3 carboxyl terminal domain are necessary for it to keep its proper structure and to promote proteolytic cleavage. The other is that the related enzyme(s) responsible for the proteolytic cleavage of the rodent Muc3 carboxyl terminal domain are Nglycosylated themselves, and inhibition of their N-glycosylation will lead to their dysfunction, and finally lead to the inhibition of proteolytic cleavage of the rodent Muc3 carboxy-terminal domain. In order to explain the results obtained from the tunicamycin experiment, a more precise experiment was carried out in which the potential N-glycosylation sites were eliminated by mutation. These experiments were designed in order to explore the possible role for the N-glycans within the SEA module in the processing of the rodent Muc3 carboxy-terminal domain. located in the second epidermal growth factor domain, while the others are clustered in the SEA module of the rodent Muc3 carboxyl terminus (Figure 2 ). We refer to the sites as N1, N2, N3, N4, N5, N6, and N7. N1, 2, and 3 reside at N-terminal side of the proteolytic cleavage site. N4, 5, 6, and 7 reside at Cterminal side of the proteolytic cleavage site. In order to explore the influence of these seven N-glycans within the SEA module on the posttranslational processing of the rodent Muc3 carboxyl terminal domain, a series of mutants were produced in the p20 construct in which the potential N-glycosylation sites were eliminated. The mutants generated include the single mutants (N1A, N2A, N3A, N4A, N5A, N6A, and N7A), double mutant (N34A), triple mutant (N345A), four N-glycosylation site mutant (N3457A), five N-glycosylation site mutant (N34567A), six N-glycosylation site mutants (N234567A and N134567A), and the seven N-glycosylation site mutant, which abolished all seven potential N-glycosylation sites within the SEA module (N1234567A) (Figure 2 ).
Identification of N-glycosylation status of N1, N2, and N3 sites
The molecular weights of the N-terminal fragments from the p20 transfectant (wild type) and the N4A, N5A, N6A, and N7A mutants were 26-30 kDa ( Figure 4B ). The products were primarily 30 kDa. The smear below 30 kDa represents incompletely glycosylated product. In contrast, the molecular weights of the N-terminal fragments from the N1A, N2A, or N3A mutants were primarily 26 kDa with some smeared products below 26 kDa that may also be due to incompletely glycosylated prod- uct. There was a 3 kDa difference in the speculated molecular weights of N-terminal fragments between the mutant transfectants and wild type (Table I) . It was previously shown that the 30 kDa N-terminal fragment is N-glycosylated (Khatri et al. 2003) . After treatment with N-glycosidase F, the molecular weight shifted to 22 kDa (Khatri et al. 2003) . Theoretically, the molecular weights of the N-terminal fragments from the N1A, N2A, or N3A mutants and the wild-type p20 transfectants should be similar if the N1, N2, and N3 sites are not posttranslationally modified because the mutation of asparagine to alanine could not cause a 4 kDa change in molecular weight. The only explanation is that N1, N2, and N3 sites are N-glycosylated. The molecular weights of the N-terminal fragments from the p20 transfectant before treatment with N-glycosidase F ranged from 26 to 30 kDa. The most predominant fragment size was 30 kDa, but shifted to 22 kDa after treatment with N-glycosidase F. N-Linked sugars at each N-glycosylation site contribute a molecular weight of 2-4 kDa, so three N-glycosylated polysaccharides chains theoretically have a molecular weight of 6-12 kDa (Table I) . Our current result is consistent with our previous report which indicated that there was an 8 kDa reduction in the size of the N-terminal cleaved fragment after deglycosylation with N-glycosidase F. We thus concluded that the N1, N2, and N3 residues are N-glycosylated.
Identification of N-glycosylation status of N4, N5, N6, and N7 sites
The cleaved C-terminal fragment from the wild-type p20 transfectant was 49 kDa, which shifted to 41 kDa after treatment with N-glycosidase F (Khatri et al. 2003) . The cleaved C-terminal fragments from N1A, N2A, N3A, or p20 transfectants were mainly 49 kDa, but the molecular weights of the C-terminal Y He et al. Table I . Numbers of N-glycans within SEA module and molecular weights of N-terminal or C-terminal fragments expected for constructs of the rodent Muc3 C-terminal domain Variables p20 N1A N2A N3A N4A N5A N6A N7A N34A N345A N3457A N34567A N134567A N234567A N1234567A 3  2  2  2  3  3  3  3  2  2  2  2  1  1  0  C-terminal  4  4  4  4  3  3  3  3  3  2  1  0  0  0  0  Expected molecular weights (kDa)  N-terminal  28 25  25  25  28  28  28  28  25  25  25  25  22  22  19  C-terminal  50 50  50  50  47  47  47  47  47  44  41  38  38  38  38 cleaved fragments from N4A, N5A, N6A, and N7A were different from those of N1A, N2A, N3A, and wild type ( Figure 4C ). Strong bands ranging from 45 to 46 kDa in N4A, N5A, N6A, and N7A mutants were observed. The cause of the 3 kDa difference in the size of the C-terminal cleaved fragments between the N4A, N5A, N6A, or N7A mutants and wild type could only be explained if N4, N5, N6, and N7 residues are N-glycosylated (Table I ). This modification increases the molecular weights of the cleaved C-terminal fragments from 46 kDa to 49 kDa. The molecular weight of the N-terminal fragment from the p20 transfectant before N-glycosidase F treatment was 49 kDa, but shifted to 41 kDa after treatment. As previously mentioned, N-linked sugars at each N-glycosylation site contribute a molecular weight of 2-4 kDa, so four N-glycosylated polysaccharide chains theoretically have a molecular weight of 8-16 kDa (Table I) . Our current result is, again, consistent with our previous report.
Multiple mutations of N-glycosylation sites confirm that they are N-glycosylated simultaneously
In order to determine if the glycosylation of all seven Nglycosylation sites in the SEA module of rMuc3 occurs simultaneously, multiple mutant forms of the protein were expressed in COS-1 cells and their products were detected by Western blotting. As shown in Figure 5B , the anti-V5 antibody was used to detect the expressed products. The Nterminal fragment from wild-type transfectants was 30 kDa, the N-terminal fragments from N1A, N2A, and N3A were around 26 kDa and the N-terminal fragments from N34A, N345A, N3457, and N34567A were similar in size to the single mutant, N3A. The molecular weight of the N-terminal fragments from both of the mutants with six mutations decreased to 23 kDa. It was consistent with their speculated molecular weights of the N-terminal fragments from all kinds of mutants (Table I) . Interestingly, when all seven N-glycosylation sites were abolished, the N-terminal cleaved fragment disappeared (discussed later). The anti-Myc antibody was also used to detect the cleavage products from the different mutants. The C-terminal fragment from the p20 transfectant was 49 kDa; the single mutation transfectants, N4A, N5A, N6A, and N7A, each produced an approximately 46 kDa product ( Figure 5C ). In the case of N34A, N345A, N3457A, N34567A, N234567, and N134567, the molecular weights of the C-terminal fragments dropped off gradually. An additional lower molecular weight band of the cleaved C-terminal fragment from the N345A transfectant was observed, as compared with the fragments from the N34A transfectant. An additional lower molecular weight band was also observed in the case of the N3457A transfectant as compared with the N345A transfectant, and in the case of the N34567A transfectant when compared with the N3457A transfectant. The C-terminal fragment from either the N234567A or N134567A transfectant was similar to that from the N34567A transfectant. It was consistent with their speculated molecular weights of the N-terminal fragments from all kinds of mutants (Table I) . When all seven N-glycosylation sites were mutated, the C-terminal fragment disappeared (discussed later). Based on the above findings, all seven N-glycosylation sites were occupied simultaneously.
Role of the seven N-glycans in the proteolytic cleavage of the SEA module
The main purpose of this work was to explore the influence of the seven N-glycans within the SEA module of rodent Muc3 on its proteolytic cleavage. All single mutants (N1A, N2A, N3A, N4A, N5A, N6A, and N7A) produced almost the same amount of uncleaved 55 kDa products as the wild type ( Figure 4B ). We thus concluded that the deletion of single N-glycans within the SEA module of the rodent Muc3 carboxyl terminus has no effect on the proteolytic cleavage of the LSKGSIVV motif.
However, when more N-glycans were abolished, an interesting phenomenon was observed. As shown in Figure 5B and C, in cases of three (N345A) and four mutations (N3457A), a very light 55 kDa band existed compared to wild type. In cases of five (N34567A) and six mutations (N234567A or N134567A), a stronger 55 kDa band appeared, and the intensities of cleaved fragments were decreased. Because the 55 kDa band was recognized by both the anti-V5 and anti-Myc antibodies, it was confirmed as an uncleaved, full-length product. When all seven N-glycans were abolished, the cleaved fragments disappeared and only the 55 kDa band was present. In other words, the proteolytic cleavage within the LSKGSIVV motif was inhibited completely when all seven N-glycans in the SEA module of the rodent Muc3 carboxyl terminus were abolished.
As previously shown, COS-1 cells transfected with p20 produced an uncleaved product when treated with tunicamycin, and the proteolytic cleavage within the LSKGSIVV motif was partially inhibited. Based on our current data, N-glycans within the SEA module of rodent Muc3 are important to the proteolytic cleavage of the SEA module of the rodent Muc3 carboxyl terminus in a eukaryotic expression system. Hundred percent of the product from the N1234567A transfectant was uncleaved. N134567A and N234567A produced 85.03% and 72.98% uncleaved products, respectively. In contrast, 48.34% of the product from the N34567A mutant was uncleaved, 1.99% of the product from the N3457A mutant was uncleaved and the products from the N34A and N345A mutants were the same as wild type ( Figure 5D ). 
Association between the N-and C-terminal cleaved fragments was independent of the seven N-glycans
The mechanism of the association between the N-and Cterminal cleaved fragments remains unclear. Since the factor(s) contributing to their association should be close to the cleavage site, we wished to determine if N-glycans in the SEA module affected their association. The spent media from all transfectants, including single mutants and multiple mutants that abolished N-glycosylation sites within the SEA module, were collected and centrifuged to clear the cell fragments. An aliquot from each sample was concentrated and subjected to SDS-PAGE and Western blotting using the anti-V5 antibody. It is clear that the dissociation of the two cleaved fragments is necessary for release of the N-terminal fragment into the spent media, but no immunoreactive product was found in the spent media from the different mutants or wild type using the anti-V5 antibody (result not shown). It is reasonable to conclude that the mechanism of association between the two cleaved fragments does not involve the N-linked polysaccharides in the SEA module of the rodent Muc3 carboxyl terminus.
Discussion
Transmembrane-tethered mucins are found in epithelial linings throughout the body. These molecules play an important role in barrier function, regulation of cell adhesion, growth, and differentiation (Carraway et al. 2000; Schroeder et al. 2001) . The carboxy-terminal regions of some transmembrane-tethered mucins have the ability to shed their extracellular domain and/or to engage in cell-signaling processes via their cytoplasmic tails which is a prominent characteristic of metastatic carcinoma, inflammatory bowel disease, and cystic fibrosis (Smorodinsky et al. 1996; McNeer et al. 1998; Parmley and Gendler 1998; Baruch et al. 1999; Shirazi et al. 2000; Buisine et al. 2001; Khatri et al. 2001) .
MUC1 SEA module cleavage and subsequent association of subunits is well documented (Ligtenberg et al. 1992; Parry et al. 2001; Levitin et al. 2005) . Recently, two groups have shown that human MUC1 SEA module cleavage is an autoproteolytic process, and the authors speculated that all cleavages of SEA module-containing proteins follow a similar route. However, it remains unclear whether the SEA module of rodent Muc3 is cleaved in the same manner as human MUC1 SEA module because of the lack of sequence similarity between the two proteins within this domain. Our aim in this study was to evaluate the role of SEA module N-glycans in the processing of the rodent Muc3 C-terminal domain. The mechanism by which the heavily glycosylated portion of these molecules is released at epithelial surfaces within the airway, the intestine, and pancreatic ducts is of considerable significance in the pathology of a number of diseases, including cystic fibrosis and cancer.
The structure of mucins consists of a central domain of tandemly repeated units rich in O-glycosylated serine and threonine residues that are flanked by unique carboxy-and aminoterminal domains. In the carboxy-terminal domain, the predicted N-glycosylated sugars were confirmed in both secreted and membrane-bound mucins, and exert different functions (Ho et al. 2003; Parry et al. 2006) , such as folding, sorting, membrane trafficking, secretion, and membrane localization.
The release of the Muc3 N-terminal fragment allows Muc3 to function as both a membrane-associated mucin and a secreted mucin. It is important to link the functional properties of Muc3 with the pathogenesis of diseases, including intestinal mucous obstruction seen in cystic fibrosis patients and inflammatory bowel disease. Adherence of Lactobacillus strains to intestinal epithelial cells in vitro leads to extracellular MUC3 secretion. Soluble Muc3 is present at high levels in the intestinal lumen of a mouse model of human cystic fibrosis (Khatri et al. 2001; Mack et al. 2003) . Until now, however, it has remained unclear what causes the dissociation of the two cleaved fragments that result from the proteolytic cleavage of both human MUC3 and rodent Muc3. It is also unclear how the N-terminal fragment can then be secreted into the intestinal lumen as a soluble form of MUC3 (Muc3).
Glycosylation is an important posttranslational modification that plays an important role in a number of physiological and biochemical properties of glycoproteins, including stability, folding, intracellular trafficking, and activity (Morais et al. 2003; Helenius and Aebi 2004) . N-Glycans are also known to modulate the antigenicity and activity of proteins. However, N-linked glycosylation does not occur at every potential site, and the role played by glycosylation in different proteins is highly variable and depends on the individual protein. Our study shows that the SEA module of rodent Muc3 is N-glycosylated at all seven potential consensus sites. The proteolytic cleavage of the SEA module was not affected when lacking one, two, three, or four N-glycans, was partially inhibited when lacking five and six N-glycosylation sites, and completely prevented when lacking all seven N-glycosylation sites. The interaction of the heterodimer was found to be independent of the N-glycosylation status of the SEA module. Thus, the N-glycosylation pattern constituted a control point for the modulation of its proteolytic cleavage in eukaryotic cells. The MUC1 SEA module produced in bacteria does not need N-glycans and can fold correctly and become cleaved (Macao et al. 2006) . Although MUC1 SEA has two potential N-glycosylation sites (N1055 and N1143), it has not been confirmed if they are actually modified. This means that N-glycans may not be necessary for correct protein folding or the cleavage caused by the folding energy in the MUC1 SEA module expressed in prokaryotic cells. However, the present results from the rodent Muc3 SEA module in COS-1 cells may not be consistent with the MUC1 SEA module produced from bacteria. The proteolytic cleavage of the rodent Muc3 SEA module was prevented if lacking more than five N-glycans, and this phenomenon could only be explained if the multiple N-glycans in the SEA module of rodent Muc3 are facilitating its folding to avoid ER degradation. The quality control mechanism for the rodent Muc3 SEA module in COS-1 cells is based on the presence of multiple N-glycans and is accompanied by the proteolytic cleavage of the LSKGSIVV motif in the ER. Incorrect folding of the rodent Muc3 SEA module in COS-1 cells, caused by the lack of N-glycans, will unavoidably lead to decreased folding energy, which is important for autoproteolysis. Thus, the lack of N-glycans ultimately results in the prevention of proteolytic cleavage.
The further shedding of the highly O-glycosylated N-terminal fragment is possibly based on the occurrence of proteolytic cleavage. If the proteolytic cleavage could be prevented through the inhibition of N-glycosylation in the SEA module, the shedding of the N-terminal cleaved fragment might also be controlled. This result has therapeutic implications for mucous meconium obstruction in cystic fibrosis patients, in which a soluble rodent Muc3 was found to be one of the constituents in a cystic fibrosis mouse model.
In conclusion, the work described here provides evidence for the functional role of N-glycans within the rodent Muc3 SEA module. They are required for the proteolytic cleavage of Muc3 in eukaryotic cells. Their contribution to the described proteolytic cleavage is not dependent upon the presence of single N-glycans, but rather on the glycosylation of all potential sites.
Material and methods
Reagents
Nitro Blue Tetrazolium (NBT)/5-bromo-4-chloroindol-3-yl phosphate (BCIP) was purchased from Roche Molecular Biochemicals (Laval, QC, Canada). Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin, and LIPOFECTAMINE TM were purchased from Life Technologies (Burlington, ON, Canada). The plasmid, pSecTag2/HydroA (pSec), and monoclonal anti-Myc and anti-V5 epitope antibodies were obtained from Invitrogen (Groningen, The Netherlands). Immobilon-P membranes were obtained from Millipore (Bedford, MA). Alkaline phosphatase-conjugated goat anti-mouse IgG was purchased from Bio-Rad Laboratories (Hercules, CA).
Role of N-glycans within the SEA module
C-Terminal domain constructs of rMuc3
The constructs, p20 and p20s/a, used in these studies have been described previously (Wang et al. 2002) . A cDNA for the C-terminal 381 amino acids of rodent Muc3 (accession number: U76551) (Khatri et al. 1997 ) was inserted into the multiple cloning site of the expression vector pSecTag2 (Invitrogen). This vector contains the murine Ig κ chain leader sequence, a Myc epitope and polyhistidine sequence at the 3 -end. The p20 construct contained a cDNA for the C-terminal 380 amino acids of rodent Muc3, a V5 epitope-tag sequence at the 5 -end, and a Myc epitope-tag and polyhistidine-tag sequences at the 3 -end. The tags of V5 and Myc were used for detections of the cleaved N-terminal fragment or C-terminal fragment. Site-specific mutation was carrid out on p20 using the Quickchange TM sitedirected mutagenesis kit (Stratagene, La Jolla, CA) to modify the Leu-Ser-Lys-Gly-Ser-Ile-Val-Val motif present within the rodent Muc3 sequence (residues 122-129; Figure 1) (Khatri et al. 1997) . The construct encoding mutant Leu-Ser-Lys-GlyAla-Ile-Val-Val was designated p20s/a. The other constructs, N89A (N1A), N97A (N2A), N121A (N3A), N160A (N4A), N170A (N5A), N180A (N6A), and N189A (N7A), produced by site-specific mutation of p20 using the Quickchange TM sitedirected mutagenesis kit (Stratagene, La Jolla, CA) are mutants for each glycosylation sites (Asn89 (N1), Asn 97 (N2), Asn 121 (N3), Asn 160 (N4), Asn 170 (N5), Asn 180 (N6), and 189 (N7)) (Figure 2 ). Codons for Asn (asparagine) were mutated to encode alanine (GCG or GCC).
The primer pairs used for PCR were:
N1A: sense: 5 -gagctacaggaccgagcctccacagaattccg-3 antisense: 5 -cggaattctgtggaggctcggtcctgtagctc-3 N2A: sense: 5 -cacagaattccgtaacttcgctgagacattcacaaagcag-3 antisense: 5 -ctgctttgtgaatgtctcagcgaagttacggaattctgtg-3 N3A: sense: 5 -ggagttatcatcaaagctctgagcaaaggcag-3 antisense: 5 -ctgcctttgctcagagctttgatgataactcc-3 N4A: sense: 5 -ggagacaaaaatcaaggctgcgacaacagttc-3 antisense: 5 -gaactgttgtcgcagccttgatttttgtctcc-3 N5A: sense: 5 -gtacaagatgccaataatgcctgttcagccttactg-3 antisense: 5 -cagtaaggctgaacaggcattattggcatcttgtac-3 N6A: sense: 5 -gccttactgtgtttcgcctcgactgccaccc-3 antisense: 5 -gggtggcagtcgaggcgaaacacagtaaggc-3 N7A: sense: 5 -cccgggtgcaaaccgccgttacagtagtcag-3 antisense: 5 -ctgactactgtaacggcggtttgcacccggg-3
The multiple mutants, N121A/N160A (N34A), N121A/ N160A/N170A (N345A), N121A/N160A/N170A/N189A (N3457A), N121A/N160A/N170A/N180A/N189A (N3456 7A), N89A/N121A/N160A/N170A/N180A/N189A (N134 567A), N97A/N121A/N160A/N170A/N180A/N189A (N234 567A), N89A/N297A/N121A/N160A/N170A/N180A/N189A (N1234567A), were all produced by site-specific mutation using the Quickchange TM site-directed mutagenesis kit, and confirmed by DNA sequencing (Invitrogen Biotechnology Co. Ltd, Shanghai, China). The N34A mutant is missing the two N-glycosylation sites N3 and N4, which are located on either side of the cleavage site. The N1234567A mutant is missing all N-glycosylation sites within the SEA module of rodent Muc3 (Figure 2) .
Cell culture and transfection experiments
COS-1 cells were obtained from the American Type Culture Collection (Rockville, MD). Cells were cultured in DMEM supplemented with 10% (v/v) FBS. Culture media also contained penicillin (100 units/mL) and streptomycin (100 μg/mL). Cells were maintained at 37
• C in a humidified atmosphere of 5% CO 2 and subcultured at a dilution of 1:10. At approximately 80-100% confluence, cells were seeded into 3.5-cm diameter tissue culture dishes at a density of approximately 8 × 10 6 cells/ dish. At 40-50% confluence, COS-1 cells were transfected with 2 μg of the plasmid and 10 μL of LIPOFECTAMINE TM in 2 mL serum-free DMEM. Transfection with vector alone served as a control in each experiment. Cells were incubated for 5 h with the transfection mixture. The mixture was then replaced with the fresh medium, and the incubation continued for a total of 40 h, with one change of medium at 16 h.
SDS-PAGE and Western blot analysis
The transfected cells were washed with PBS and lysed in 200 μL of SDS sample buffer. Cell lysates and media were subjected to SDS-PAGE (12%) under both reducing and nonreducing conditions (i.e., boiling for 3 min with or without DTT), and then transferred onto Immobilon-P membranes. Membranes were blocked for 1 h at 22
• C with 20 mM Tris/HCl buffer (pH 7.4) containing 0.15 M NaCl and 3% (w/v) BSA. Immunostaining was carried out at 4
• C overnight with the anti-Myc or anti-V5 antibody, followed by incubation with a 1:3000 dilution of alkaline phosphatase-conjugated goat anti-mouse IgG antibody for 1 h at 22
• C. Positive bands were detected with the NBT/BCIP substrate system. SeeBlue TM plus 2 (Invitrogen) was used as the molecular mass standard. (Wang et al. 2002) except that the chase media contained 0.24 mg/mL cysteine and 0.15 mg/mL methionine. Cells were lysed in the 300 μL RIPA buffer, centrifuged, and supernatants precleared with 50 μL of Protein A-agarose. Specific protein products were immunoprecipitated during a 16-h incubation at 4
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• C with an anti-V5 antibody in the presence of 50 μL of Protein A-agarose. Immunoprecipitates were washed twice in the RIPA buffer and once in the 10 mM Tris/HCl buffer (pH 7.4) containing 0.1% NP40, and then subjected to SDS/PAGE. Gels were rinsed with distilled water, fixed in 30% methanol/10% acetic acid, dried and exposed to X-ray film (Kodak X-Omat XAR-5) for 1-3 days. In some experiments, transfected cells were also incubated in the presence of tunicamycin (20 μg/mL) 2 h prior to the radioactive pulse. Tunicamycin was maintained throughout the entire pulse (15 min) and chase (0-4 h) periods.
Determination of the proteolytic cleavage inhibition of the rMuc3 SEA module
Inhibition of cleavage was determined by densitometer scans to calculate the percentage of uncleaved reporter running at 55 kDa and cleaved reporter protein band (30 kDa). The
